FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Genix Pharmaceuticals Corporation Stock AnalysisComprehensive stock analysis for Genix Pharmaceuticals Corporation (GENPF) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisGENPF
GENPF
Genix Pharmaceuticals Corporation
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
GENPF
Home🔹Stocks🔹Genix Pharmaceuticals Corporation

Genix Pharmaceuticals Corporation

GENPF•OTC

Genix Pharmaceuticals Corporation

GENPF•OTC
Market cap
$835.06K
Sentiment

Your view on GENPF

Mkt Cap
$835.06K
Sentiment
Your view
GENPF
Genix Pharmaceuticals Corporation
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
GENPF
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Genix Pharmaceuticals Corporation

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Sina Salehi Pirooz
Headquarters
10022 – 102 Avenue, Vancouver, BC, CA
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Sina Salehi Pirooz
Headquarters
10022 – 102 Avenue, Vancouver, BC, CA
Description

Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with focus on nutraceuticals and pharmaceuticals in Canada. The company develops Flu-X, an anti-viral, anti-flu, and common colds coronavirus oral and spray herbal product; Renochlor, a dietary supplement to aid in the restoration of kidney health and kidney function; and Sucanon, an insulin sensitizer that lowers blood sugar by increasing the muscle, fat, and liver's sensitivity to insulin. It also markets and sells nutraceuticals and pharmaceutical products, such as bee propolis capsules, calcium liquid softgels, seal oil softgels, marine lipid softgels, Lecithin softgels, fish oil softgels, EPO softgels, and spirulina powder, as well as eye ointments and drops. The company was formerly known as Alta Natural Herbs & Supplements Ltd. and changed its name to Genix Pharmaceuticals Corporation in June 2019. Genix Pharmaceuticals Corporation was incorporated in 1993 and is based in Vancouver, Canada.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News